Document:

Exhibit
10.4

 

EMPLOYMENT
AGREEMENT

 

BETWEEN

 

MAM SOFTWARE GROUP, INC.

 

And

 

LEE
BROAD

(Executive)

 

THIS
EMPLOYMENT AGREEMENT (this “Agreement”), dated as of July 1, 2013
(the “Effective Date”) is entered into by and between MAM Software Group, Inc., a Delaware corporation (the “Company”),
and Lee Broad, an individual with a physical address at [_______] (the “Executive”) (collectively, the “Parties,”
individually, a “Party”).

 

WITNESSETH:

 

WHEREAS,
the Board of Directors of the Company (the “Board”) has requested and the Executive has agreed to provide services
to the Company as its Chief Technology Officer in order to continue his efforts on behalf of the Company; and

 

WHEREAS,
the Board has determined that it is in the best interest of the Company, its affiliates, and its stockholders to assure that the
Company will have the continued dedication of the Executive, notwithstanding the possibility, threat, or occurrence of a Change
of Control (as defined Article Six herein); and

 

WHEREAS,
the Board has determined that it is in the best interests of the Company and its stockholders to indemnify the Executive for claims
for damages arising out of or relating to the performance of such services to the Company in accordance with the terms and conditions
set forth in this Agreement and pursuant to Delaware law; and

 

WHEREAS,
as an inducement to serve and in consideration for such services, the Company has agreed to indemnify the Executive for claims
for damages arising out of or relating to the performance of such services to the Company in accordance with the terms and conditions
set forth in a separate agreement, which indemnification agreement is attached as an exhibit hereto and is incorporated herein
by reference; and

 

WHEREAS,
in order to accomplish these objectives and establish the rights, duties and obligations of the Parties, which shall be generally
stated herein and which may be more fully stated in other agreements between the Parties, including equity-based agreements, indemnity
agreements, and other employment or incentive related agreements as the Company or the Board may adopt from time to time, the Board
has caused the Company to enter into this Agreement;

 

     

     

    

 

NOW,
THEREFORE, in consideration of the premises and the mutual covenants and agreements set forth herein, the Parties, intending to
be legally bound, hereby agree as follows:

 

ARTICLE
ONE 

 

DEFINITIONS

 

1.           Definitions.
As used in this Agreement:

 

1.1           The
term “Accrued Obligations,” when used in the case of the Executive’s death or disability shall mean the sum of
(1) that portion of the Executive’s Base Salary that was not previously paid to the Executive from the last payment date
through the Date of Termination and (2) any Severance Benefit due.

 

1.2           The
term “Automatic Extension” shall have the meaning set forth in Section 2.2 herein.

 

1.3           The
term “Base Salary” shall have the meaning set forth in Section 3.1 herein.

 

1.4           The
term “Board” shall have the meaning set forth in the recitals.

 

1.5           The
term “Cause” shall have the meaning set forth in Section 4.3 herein.

 

1.6           The
term “Change of Control” means the acquisition by any individual, entity or group (within the meaning of Section 13(d)(3)
or 14(d)(2) of the Exchange Act) (a “Person”) of beneficial ownership (within the meaning of Rule 13d-3 promulgated
under the Exchange Act) of 50% or more of either (A) the then outstanding Common Shares the Company (the “Outstanding Shares”)
or (B) the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election
of directors (the “Outstanding Voting Securities”); provided, however, that for purposes of this Agreement, the following
acquisitions shall not constitute a Change of Control: (x) a Company-sponsored recapitalization that is approved by the individuals
who, as of the date of this Agreement, constitute the Company’s Board (the “Incumbent Board”); (y) a capital
raise initiated by the Company where a majority of the Incumbent Board remains until the next annual shareholders’ meeting
after the closing date of the raise; and (z) an acquisition of another company or asset(s) initiated by the Company and where the
Company’s shareholders immediately after the transaction own at least 51% of the equity of the combined concern.

 

1.7           The
term “Common Stock” shall mean the Common Stock, par value $0.0001, of the Company.

 

1.8           The
term “Compensation Committee” shall mean the Compensation Committee of the Company.

 

     

     

    

 

1.9           The
term “Company Group” shall mean the Company and any other corporation or trade or business required to be
aggregated with the Company which constitutes a single Company under Code Section 414(b) or Code Section 414(c) with the
Company, except that in applying Code Section 1563(a)(1), (2), and (3), the language “at least 50 percent” is
used instead of “at least 80 percent.”

 

1.10         The
term “Corporate Documents” shall mean the Company’s Certificate of Incorporation, as amended and/or its Bylaws,
as amended.

 

1.11         The term
“Effective Date” shall have the meaning set forth in the preamble.

 

1.12         The term
“Good Reason” shall have the meaning set forth in Section 4.3(c) herein.

 

1.13         The
term “Initial Term” shall have the meaning set forth in Section 2.2 herein.

 

1.14         The
term “Separation from Service” shall mean the Executive’s termination of employment with the Company Group for
any reason which constitutes a “separation from service” under Code Section 409A. Notwithstanding the foregoing, the
Executive’s employment relationship with the Company Group is considered to remain intact while the individual is on military
leave, sick leave or other bona fide leave of absence if there is a reasonable expectation that the Executive will return to perform
services for the Company Group and the period of such leave does not exceed six months, or if longer, so long as the Executive
retains a right to reemployment with the Company under applicable law or contract. Solely for purposes of determining whether a
Separation from Service has occurred, the Company will determine whether the Executive has terminated employment with the Company
Group based on whether it is reasonably anticipated by the Company and the Executive that the Executive will permanently cease
providing services to the Company Group, whether as an employee or independent contractor, or that the services to be performed
by the Executive, whether as an employee or independent contractor, will permanently decrease to no more than 20% of the average
level of bona fide services performed, whether as an employee or independent contractor, over the immediately preceding 36-month
period or such shorter period during which the Executive was performing services for the Company Group. If a leave of absence occurs
during such 36-month or shorter period which is not considered a Separation from Service, unpaid leaves of absence shall be disregarded
and the level of services provided during any paid leave of absence shall be presumed to be the level of services required to receive
the compensation paid with respect to such leave of absence.

 

1.15         The
term “Severance Benefit” shall have the meaning set forth in Section 4.6(b)(i) herein. The term may also be referred
to as a “Severance Amount.”

 

1.16         The
term “Without Cause” shall have the meaning set forth in Section 4.3(b) herein.

 

1.17         The
term “Without Good Reason” shall have the meaning set forth in Section 4.3 herein.

 

     

     

    

 

ARTICLE
TWO 

 

POSITION
& DUTIES

 

2.           Employment.

 

2.1          Title.
The Executive shall serve as the Chief Technology Officer of the Company and agrees to perform services for the
Company and such other affiliates of the Company, as described in Section 2.3 herein.

 

2.2          Term.
The Executive’s employment shall be for an initial term of two (2) year (“Initial Term”), commencing on the Effective
Date. The Executive’s employment shall be automatically extended on the day after the second year anniversary of the Effective
Date (“Automatic Extension”), and on each anniversary date thereof, for additional one (1) year periods
unless, with respect to any such Automatic Extension, Executive’s employment is terminated by either party.

 

2.3          Duties
and Responsibilities. The Executive shall report to the Chief Executive and in his capacity as an officer of the Company shall
perform such duties and services as may be appropriate and as are assigned to him by the Chief Executive Officer. During the term
of this Agreement Executive shall, subject to the direction of the Chief Executive Officer, [________], and shall perform such duties as are customarily performed by the Chief Technology
Officer of a company such as the Company or as are otherwise delegated to him from time to time by the Chief Executive Officer.

 

2.4          Performance
of Duties. During the term of the Agreement, except as otherwise
approved by the Board or as provided below, the Executive agrees to devote his full business time,
effort, skill and attention to the affairs of the Company and its
subsidiaries, will use his
best efforts
to promote the interests of the Company, and will discharge his
responsibilities in a diligent and faithful manner, consistent with sound
business practices. The foregoing shall not, however, preclude Executive from devoting reasonable time, attention and energy in
connection with the following activities, provided that such activities do not materially interfere with the performance of his
duties and services hereunder:

 

(a)          serving
as a director or a member of a committee of any company or organization, if serving in such capacity does not involve any conflict
with the business of the Company or any subsidiary and such other company or organization is not in competition, in any manner
whatsoever, with the business of the Company or any of its subsidiaries;

 

(b)          fulfilling
speaking engagements;

 

(c)          engaging
in charitable and community activities;

 

(d)          managing
his personal business and investments; and

 

     

     

    

 

(e)          any
other activity approved of by the Board. For purposes of this Agreement, any activity specifically listed on Schedule
A shall be considered as having been approved
by the Board.

 

2.5          Representations
and Warranties of the Executive with Respect to Conflicts. Past Employers and Corporate
Opportunities. The Executive represents and warrants that:

 

(a)          his
employment by the Company will not conflict with any obligations which he has to any other person, firm or entity; and

 

(b)          he
will not, without disclosure to and approval of the Board, directly or indirectly, assist or have an active interest in (whether
as a principal, stockholder, lender, employee, officer, director, partner, venturer, consultant or otherwise) in any person, firm,
partnership, association, corporation or business organization, entity or enterprise that competes with or is engaged in a business
which is substantially similar to the business of the Company; provided, however, that ownership of not more than two percent
(2%) of the outstanding securities of any class of any publicly held corporation shall not be deemed a violation of this Section
2.5; provided, further, that any investment specifically listed on Schedule A shall not be deemed a violation of this Section 2.5.

 

2.6          Activities
and Interests with Companies Doing Business with
the Company.
In addition to those activities and interests of Executive disclosed on Schedule A attached hereto, Executive shall promptly
disclose to the Board, in accordance with the Company’s policies, full information concerning any interests, direct or indirect,
he holds (whether as a principal, stockholder, lender, executive, director, officer, partner, venturer, consultant or otherwise)
in any business which, as reasonably known to Executive, purchases or provides services or products to, the Company or any of
its subsidiaries, provided that the Executive need not disclose any such interest resulting from ownership of not more than two
(2%) of the outstanding securities of any class of any publicly held corporation.

 

2.7          Other
Business Opportunities. Nothing in this Agreement shall be deemed to preclude the Executive from participating in other business
opportunities if and to the extent that: (a) such business opportunities are not directly competitive with, similar to the business
of the Company, or would otherwise be deemed to constitute an opportunity appropriate for the Company; (b) the Executive’s
activities with respect to such opportunities do not have a material adverse effect on the performance of the Executive’s
duties hereunder, and (c) the Executive’s activities with respect to such opportunity have been fully disclosed in writing
to the Board.

 

2.8          Reporting
Location. For purposes of this Agreement, the Executive’s reporting location shall be Barnsley, England, which shall
include the metropolitan or suburban area within a 50-mile radius from the Company’s current office; provided, however,
that it is understood and agreed that Executive’s responsibilities include frequent travel to the United States in respect
of technology matters involving US products, services, sales, and technological initiatives related thereto.

 

     

     

    

 

ARTICLE
THREE 

 

COMPENSATION

 

3.           Compensation.

 

3.1          Base
Salary. Executive shall receive an initial annual base salary of one hundred and fifty
thousand British Pounds Sterling (125,000.00 GBP), payable monthly in arrears (the “Base Salary”) and subject to all
applicable withholding requirements. The Base Salary shall be reviewed by the Board annually for adequacy.

 

3.2          Annual
Incentive. Executive will be eligible to receive annual cash incentives payable for the achievement of performance goals established
by the Compensation Committee; provided, however, that no covenants in any then-existing debt facility or any then- outstanding
debt issuance are or would be violated by payment of such Annual Incentive, if paid in cash. An Annual Incentive payment may be
made in cash if such existing covenants have been specifically and explicitly waived in writing by any then-lender or investor;
provided, however, that no Annual Incentive can be paid if the Company would be required to pay for such a waiver. Any
unpaid Annual Incentive payment will be accrued or paid in Company common stock.

 

3.3          The
actual earned Annual Incentive, if any, payable to Executive for any performance period will depend upon the extent to which the
applicable performance goal(s) specified by the Compensation Committee are achieved and will be decreased or increased for under-
or over- performance. Except as specifically provided herein, Executive’s Annual Incentive will be subject to the terms and
conditions of a formal bonus plan that may be adopted by the Compensation Committee from time to time; provided, that if there
is no formal bonus plan that has been established by the Company, the Executive’s Annual Incentives shall be established
each year by the Compensation Committee.

 

3.4          Long
Term Incentives.

 

(i)          Long-Term
Ongoing Performance Equity Incentive. Executive
will be eligible to receive long-term performance equity incentives at a level and on conditions as the Compensation Committee
shall establish. Any long-term incentive will be subject to terms and conditions of the Company’s 2007 Stock Incentive Plan
(the “LTIP”), or any successor thereto, or any other equity-based compensation plan that may be established by the
Committee and approved by the shareholders. In addition, any long-term incentive will be subject to the Committee’s standard
terms and conditions for the applicable type of award, including vesting criteria such as continued service or performance objectives.

 

(ii)         Stock
Grant. Executive will be granted 250,892
restricted common shares of MAM Software Group, Inc. (the “Stock Grant”) as part of his equity compensation component. The stock
will vest as follows:

 

     

     

    

 

a.           20%
of the Stock Grant will vest when the price of the Common Stock of the Parent has reached $6 per share.

 

b.           30%
of the Stock Grant will vest when the price of the Common Stock of the Parent has reached $7 per share.

 

c.           30%
of the Stock Grant will vest when the price of the Common Stock of the Parent has reached $8 per share.

 

d.           20%
of the Stock Grant will vest when the price of the Common Stock of the Parent has reached $9 per share.

 

3.5          Participation
In Benefit Plans.

 

(a)          Retirement
Plans. Executive shall be entitled to participate,
without any waiting or eligibility periods, in all qualified retirement plans provided to other executive officers and other key
employees.

 

(b)          Employee
Benefit Plans and Insurance. The Executive
shall have the right to participate in employee benefit plans and insurance programs of the Company that the Company may sponsor
from time to time and to receive customary Company benefits, if those benefits are so offered. Nothing herein shall obligate Executive
to accept such benefits if and when they are offered.

 

(c)          Vacation.

 

(i)          The
Executive shall be entitled to five (5) weeks of vacation, with pay. No more than 1.5 times (1.5x) Executive’s authorized
annual vacation allocation may be accrued, at any given time. In the event that Executive has reached his maximum authorized vacation
allocation, accrual will not re-commence until Executive uses some of his paid vacation credit and thereby brings the balance below
his maximum. Accrued paid vacation credit forfeited because of an excess balance cannot be retroactively reapplied.

 

(ii)         Pay
will only be provided for any unused, accrued paid vacation credit at the time of Executive’s separation from the business
by the Company due to a reduction in force, by Executive upon retirement, by his resignation for Good Reason (as defined herein),
or upon his death or disability, provided that Executive has been a regular full-time employee for three calendar months prior
to such event. Termination of employment for Cause by the Company, or Executive’s resignation (including any resignation
that is without Good Reason), will result in the forfeiture of any unused paid vacation credit.

 

(d)          Paid
Holidays. The Executive shall be entitled
to such paid holidays as are generally available to all employees.

 

     

     

    

 

3.6          Relocation
and Business-related Expenses. In the event that Executive is required to move from his
primary residence and consents to such move, then Executive shall be
provided with relocation assistance as provided below:

 

(a)          Housing
and Temporary Lodging. The Company will pay
the costs, for the Executive and his family, of house-hunting trips and the cost of transporting the Executive, his spouse, furniture,
household effects, and vehicles, to the area in which the Company will be headquartered. In addition, the Company will pay the
cost of the Executive’s travel, temporary living expenses, including housing, whether hotel or apartment, and meals, during
the period prior to the Executive’s move to the city in which the Company will be headquartered.

 

(b)          Reimbursement.
Executive shall be entitled to reimbursement within a reasonable time for all properly documented and approved expenses for travel.
The Company shall reimburse business expenses of Executive directly related to Company business, including, but not limited to,
airfare, lodging, meals, travel expenses, medical expenses while traveling not covered by insurance, business entertainment, expenses
associated with entertaining business persons, local expenses to governments or governmental officials, tariffs, applicable taxes
outside of the United States or United Kingdom, special expenses associated with travel to certain countries, supplemental life
insurance or supplemental insurance of any kind or special insurance rates or charges for travel outside the Executive’s
country of residence (unless such insurance is being provided by the Company), rental cars and insurance for rental cars, and any
other expenses of travel that are reasonable in nature or that have been otherwise pre-approved. Executive shall be governed by
the travel and entertainment policy in effect at the Company.

 

(c)          Transportation
Allowance. The Executive shall be entitled
to a company car in accordance with MAM Software Ltd.’s Company Car scheme.

 

3.7          Severance
Benefit. In the event that Executive’s employment is terminated, other than for
Cause, Executive shall receive severance pursuant to Section 4.6(b)(i) herein.

 

3.8          Payroll
Procedures and Policies. All payments required to be made by the Company to the Executive
pursuant to this Article Three shall be paid on a regular basis in accordance with the Company’s normal payroll procedures
and policies.

 

ARTICLE
FOUR 

 

TERMINATION
OF EMPLOYMENT

 

4.1          Events
of Termination. Executive’s employment, the Employment Period, the Base Salary,
and any and all other rights of Executive under this Agreement or otherwise as an employee of the Company will terminate (except
as otherwise provided in this Section 4):

 

     

     

    

 

(a)
upon the death of the Executive;

 

(b)
upon termination of employment due to the Disability
of the Executive;

 

(c)
upon termination by the Company for Cause;

 

(d)
upon resignation of employment by the Executive
without Good Reason;

 

(e)
upon termination by the Company without
Cause;

 

(f)
upon the resignation of employment by Executive
for Good Reason.

 

Upon
termination of Executive’s employment, as provided above or otherwise, Executive’s rights respecting benefits, stock
options, restricted stock, and other equity awards will be determined under the applicable plan or program providing the same.

 

4.2         Definition
and Determination of Disability. If the Company
determines in good faith that the Disability (as defined below) of the Executive has occurred during the Employment Term, the Company
may give the Executive notice of its intention to terminate the Executive’s employment. In such event, the Executive’s
employment hereunder shall terminate effective on the 30th day after receipt of such notice by the Executive (the “Disability
Effective Date”); provided, that, within the 30-day period after such receipt, the Executive shall not have returned
to full-time performance of the Executive’s duties. For purposes of this Agreement, “Disability” shall mean the
absence of the Executive from the Executive’s duties hereunder on a full-time basis for an aggregate of 180 days within any
given period of 270 consecutive days (in addition to any statutorily required leave of absence and any leave of absence approved
by the Company) as a result of incapacity of the Executive, despite any reasonable accommodation required by law, due to bodily
injury or disease or any other mental or physical illness, which will, in the opinion of a physician selected by the Company or
its insurers and acceptable to the Executive or the Executive’s legal representative, be permanent and continuous during
the remainder of the Executive’s life.

 

4.3         Definition
of “Cause,” “Without Cause,” and “Good Reason.”

 

(a)         Termination
for Cause.

 

The
Executive’s employment hereunder may be terminated for Cause. For purposes of this Agreement, “Cause” shall
mean:

 

(i)          the
willful and continued failure of the Executive to perform substantially the Executive’s duties hereunder (other than any
such failure resulting from bodily injury or disease or any other incapacity due to mental or physical illness) after a written
demand for substantial performance is delivered to the Executive by the Board or the Chairman of the Company, which specifically
identifies the manner in which the Board or the Chairman of the Company believes the Executive has not substantially performed
the Executive’s duties; or

 

     

     

    

 

(ii)         the
willful engaging by the Executive in illegal conduct or gross misconduct that is materially and demonstrably detrimental to the
Company and/or its affiliated companies, monetarily or otherwise.

 

For
purposes of this provision, no act, or failure to act, on the part of the Executive shall be considered “willful” unless
done, or omitted to be done, by the Executive in bad faith or without reasonable belief that the Executive’s action or omission
was in the best interests of the Company. Any act, or failure to act, based upon authority given pursuant to a resolution duly
adopted by the Board, upon the instructions of the Chairman or another Board Member of Company, or based upon the advice of counsel
for the Company shall be conclusively presumed to be done, or omitted to be done, by the Executive in good faith and in the best
interests of the Company and its affiliated companies. The cessation of employment of the Executive shall not be deemed to be for
Cause unless and until there shall have been delivered to the Executive a copy of a resolution duly adopted by the affirmative
vote of not less than two-thirds of the entire membership of the Board then in office, excluding the Executive, at a meeting of
the Board called and held for such purpose (after reasonable notice is provided to the Executive and the Executive is given an
opportunity, together with counsel, to be heard before the Board) finding that, in the good faith opinion of the Board, the Executive
is guilty of the conduct described in subparagraph (i) or (ii) above, and specifying the particulars thereof in detail.

 

(iii)        Executive’s
material violation of any Company policy or code of ethics or conduct that may be in force from time to time;

 

(iv)        the
appropriation (or attempted appropriation) of a material business opportunity of the Company without first presenting it to the
Company in writing and giving it a reasonable opportunity to accept or reject such opportunity, including attempting to secure
or securing any personal profit in connection with any transaction entered into on behalf of the Company;

 

(v)         the
Executive’s conviction of, or plea of nolo contendere to, any felony of theft, fraud, embezzlement or violent crime, or the
entering of a guilty plea or a plea of non contendere for any other crime for which imprisonment is a punishment.

 

(vi)        the
misappropriation (or attempted misappropriation) of any of the Company’s funds or property.

 

(b)         Termination
without Cause.

 

The
determination of whether the Executive’s employment is terminable for Cause shall be made solely by the Company’s Board
of Directors, which shall act in good faith in making such determination. All terminations by the Company that are not for Cause,
or on the occasion of the Executive’s death or disability shall be considered Without Cause.

 

     

     

    

 

(c)         Termination
for Good Reason.

 

The
Executive’s employment hereunder may be terminated for Good Reason. For all purposes under this Agreement, “Good Reason”
shall mean the occurrence of one or more of the following events arising without the express written consent of the Executive,
but only if the Executive notifies the Company in writing of the event within sixty (60) days following the occurrence of the
event, the event remains uncured after the expiration of thirty (30) days from receipt of such notice, and the Executive resigns
effective no later than thirty (30) days following the Company’s failure to cure the event:

 

(i)          a
material diminution in the Executive’s Base Salary;

 

(ii)         a
material diminution in the Executive’s authority, duties, or responsibilities (including status, offices, titles and reporting
requirements), duties, functions, responsibilities or authority as contemplated by Section 2.3 of this Agreement, or any other
action by the Company that results in a diminution in such position, duties, functions, responsibilities or authority, excluding
for this purpose an isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company
promptly after receipt of notice thereof given by the Executive as provided for herein;

 

(iii)        a
material diminution in the authority, duties, or responsibilities of the supervisor to whom the Executive is required to report,
including a requirement that the Executive report to any corporate officer or employee instead of reporting directly to the Chief
Executive Officer or the Board of Directors of the Company;

 

(iv)        a
material diminution in the budget over which the Executive retains authority;

 

(v)         the
Company or a subsidiary thereof requiring the Executive to be permanently based anywhere other than within fifty (50) miles from
the location other than as provided in Section 2.8 of this Agreement;

 

(vi)        any
other action that constitutes a material breach by the Company of the Agreement;

 

(vii)       the
Executive’s ceasing to be the highest ranking executive officer of the Company; or

 

(viii)      Any
failure by the Company to comply with and satisfy Section 7.1 of
this Agreement.

 

A
resignation of employment by Executive for any other reason or under any other circumstances will be a resignation “Without
Good Reason.”

 

     

     

    

 

4.4          Notice
of Termination. Any termination of the Executive’s
employment hereunder by the Company or by the Executive (other than a termination pursuant to Section 4.1(a)) shall be communicated
by a Notice of Termination (as defined below) to the other party hereto. For purposes of this Agreement, a “Notice of Termination”
shall mean a notice which (a) indicates
the specific termination provision in this Agreement relied upon, (b) in the case of a termination for Disability, Cause, or Good
Reason, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive’s
employment under the provision so indicated, and (c) specifies the Date of Termination (as defined in Section 4.5 below); provided,
however, that notwithstanding any provision in this Agreement to the contrary, a Notice of Termination given in connection with
a termination for Good Reason shall be given by the Executive within a reasonable period of time, not to exceed 60 days, following
the occurrence of the event giving rise to such right of termination. The failure by the Company or the Executive to set forth
in the Notice of Termination any fact or circumstance which contributes to a showing of Disability, Cause or Good Reason shall
not waive any right of the Company or the Executive hereunder or preclude the Company or the Executive from asserting such fact
or circumstance in enforcing the Company’s or the Executive’s rights hereunder.

 

4.5          Date
of Termination. For purposes of this Agreement,
the “Date of Termination” shall mean the effective date of termination of the Executive’s employment hereunder,
which date shall be (a) if the Executive’s employment is terminated by the Executive’s death, the date of the Executive’s
death, (b) if the Executive’s employment is terminated because of the Executive’s Disability, the Disability Effective
Date, (c) if the Executive’s employment is terminated by the Company (or applicable affiliated company) for Cause or by the
Executive for Good Reason, the date on which the Notice of Termination is given, and (d) if the Executive’s employment is
terminated for any other reason, the date specified in the Notice of Termination, which date shall in no event be earlier than
the date such notice is given; provided, however, that if within 30 days after any Notice of Termination is given, the party
receiving such Notice of Termination notifies the other party that a dispute exists concerning the termination, the Date of Termination
shall be the date on which the dispute is finally determined, either by mutual written agreement of the parties or by a final judgment,
order or decree of a court of competent jurisdiction (the time for appeal therefrom having expired and no appeal having been perfected).

 

4.6          Obligations
of the Company upon Termination.

 

(a)          General.
Should Executive’s employment with the Company be terminated by the Company Without Cause or should Executive resign his
employment with the Company for Good Reason, then, subject to Executive executing, and failing to revoke during any applicable
revocation period, the Severance Agreement and General Release attached as Exhibit A
to this Agreement within time period provided immediately herein, after Executive’s termination of employment, the Company
will provide to Executive the following:

 

(b)          Good
Reason; Other Than for Cause, Death or Disability.
If, during the Employment Term, the Company (or applicable affiliated company) shall terminate the Executive’s employment
hereunder other than for Cause or Disability or the Executive shall terminate the Executive’s employment for Good Reason:

 

     

     

    

 

(i)          the
Company shall pay to the Executive (either in a lump sum or on in equal monthly installments over a twelve (12) month period after
the Date of Termination, at the Company’s option) an amount equal to 12 months salary at the level of the Executive’s
Base Salary then in effect, (such 12 months amount is hereinafter referred to as the “Severance Amount”);

 

(ii)         all
stock appreciation rights and restricted stock shall immediately vest;

 

(iii)        all
vested stock options and stock appreciation rights shall be payable in Common Stock;

 

(iv)        all
performance share units that would vest in the course of any fiscal year shall vest on a pro rata basis; and

 

(v)         to
the extent not theretofore paid or provided, the Company shall timely pay or provide to the Executive any other amounts or benefits
required to be paid or provided or which the Executive is eligible to receive under any annual bonus plan, program, policy, practice
or arrangement or contract or agreement of the Company and its affiliated companies (such other amounts and benefits hereinafter
referred to as the “Other Benefits”).

 

(c)          Death.
If the Executive’s employment is terminated by reason of the Executive’s death during the Employment Term, this Agreement
shall terminate without further compensation obligations to the Executive’s legal representatives under this Agreement, other
than for (i) payment of Accrued Obligations (which shall be paid to the Executive’s estate or beneficiary, as applicable,
in a lump sum in cash within 90 days of the Date of Termination) and the timely payment or settlement of any other amount pursuant
the Other Benefits and (ii) treatment of all other compensation under existing plans as provided by the terms and rules of those
plans.

 

(d)          Disability.
If the Executive’s employment is terminated by reason of the Executive’s Disability during the Employment Term, this
Agreement shall terminate without further compensation obligations to the Executive, other than for (i) payment of Accrued Obligations
(which shall be paid to the Executive in a lump sum in cash within 90 days of the Date of Termination) and the timely payment or
settlement of any other amount pursuant to the Other Benefits and (ii) treatment of all other compensation under existing plans
as provided by the terms and rules of those plans.

 

     

     

    

 

(e)          Cause;
Other than for Good Reason. If the Executive’s
employment is terminated for Cause during the Employment Term, this Agreement shall terminate without further compensation obligations
to the Executive other than the obligation to pay to the Executive Base Salary through the Date of Termination plus the amount
of any compensation previously deferred by the Executive, in each case to the extent theretofore unpaid. If the Executive voluntarily
terminates the Executive’s employment during the Employment Term, and such termination is Without Good Reason, this Agreement
shall terminate without further compensation obligations to the Executive, other than for the that portion Executive’s Base
Salary that was not previously paid to the Executive from the last payment date through the effective date of the Executive’s
voluntary termination and the timely payment or provision of the Other Benefits, as provided in any applicable plan, and the Executive
shall have no further obligations nor liability to the Company. In such case, any amounts owed to the Executive shall be paid to
the Executive in a lump sum in cash within 90 days of the Date of Termination subject to applicable laws and regulations.

 

4.7          Change
of Control.

 

(a)          If,
within 12 months after a Change of Control, Executive’s position is terminated by the Company without Cause or Executive
resigns his employment for Good Reason, then, subject to Executive executing, and failing to revoke during any applicable revocation
period, the Severance Agreement and General Release attached as Exhibit A
to this Agreement within forty-five (45) days after Executive’s termination of employment, the Executive shall be entitled
to such benefits as if he were terminated Without Cause or For Good Reason.

 

(b)          Subject
to Section 4.8 or any other agreement between the Company and the Executive that may be entered between them from time to time,
such lump sum payments under this Section 4.7 will be made no later than sixty (60) days following the Executive’s Separation
from Service on or after the date the Executive’s employment is terminated. Upon Executive’s execution and delivery
of Exhibit A, a Company representative
will execute and deliver to Executive Exhibit A.
assuming the requirements of this Agreement have been met. Severance payments do not result in extending employment beyond the
termination date.

 

4.8          Code
Section 409A.

 

(a)          General.
Notwithstanding any provision to the contrary in this Agreement, if the Executive is deemed at the time of his Separation from
Service from the Company to be a “specified employee” for purposes of Section 409A(a)(2)(B)(i) of the Code and if any
amounts otherwise payable pursuant to this Agreement within the first six (6) months following the Executive’s Separation
from Service would be subject to the excise tax imposed by Section 409A of the Code, then payment of such portion of the benefits
subject to the excise tax shall be suspended and shall be paid in a lump sum to the Executive on the first business day following
the expiration of six (6) months from the date of the Executive’s Separation from Service.

 

     

     

    

 

(b)          409A
Compliance. It is intended that any amounts payable under this Agreement and the Company’s and Executive’s exercise
of authority or discretion hereunder shall comply with Internal Revenue Code Section 409A (including the Treasury regulations and
other published guidance relating thereto) so as not to subject Executive to the payment of any interest or additional tax imposed
under Internal Revenue Code Section 409A. To the extent any amount payable to Executive from Company, per this Agreement or otherwise,
would trigger the additional tax imposed by Internal Revenue Code Section 409A, the parties agree to adopt any necessary amendments
to this Agreement in order to avoid such additional tax.

 

ARTICLE
FIVE 

 

INDEMNIFICATION

 

5.           Indemnification.
The Executive shall be indemnified and held harmless pursuant to the terms and conditions set forth in the Indemnity Agreement
substantially in the form attached as Exhibit B
hereto.

 

ARTICLE
SIX 

 

CONFIDENTIALITY

 

6.          Confidentially;
Non-Competition; and Non-Solicitation.

 

6.1           Confidentiality.
In consideration of employment by the Company and Executive’s receipt of the salary and other benefits associated with Executive’s
employment, and in acknowledgment that (a) the Company is engaged in the automotive software business, (b) maintains secret and
confidential information, (c) during the course of Executive’s employment by the Company such secret or confidential information
may become known to Executive, and (d) full
protection of the Company’s business makes it essential that no employee appropriate for his or her own use, or disclose
such secret or confidential information, Executive agrees that during the time of Executive’s employment and for a period
of two (2) years following the termination of Executive’s employment with the Company, Executive agrees to hold in strict
confidence and shall not, directly or indirectly, disclose or reveal to any person, or use for his own personal benefit or for
the benefit of anyone else, any trade secrets, confidential dealings, or other confidential or proprietary information of any kind,
nature, or description (whether or not acquired, learned, obtained, or developed by Executive alone or in conjunction with others)
belonging to or concerning the Company or any of its subsidiaries, except (i) with the prior written consent of the Company duly
authorized by its Board, (ii) in the course of the proper performance of Executive’s duties hereunder, (iii) for information
(x) that becomes generally available to the public other than as a result of unauthorized disclosure by Executive or his affiliates
or (y) that becomes available to Executive on a non-confidential basis from a source other than the Company or its subsidiaries
who is not bound by a duty of confidentiality, or other contractual, legal, or fiduciary obligation, to the Company, or (iv) as
required by applicable law or legal process.

 

     

     

    

 

6.2           Non-Competition.
During Executive’s employment with the Company and for so long as Executive receives any Severance Benefit or is receiving
any Severance Amount provided under this agreement in respect of the termination of his employment, Executive shall not be engaged
as an officer or executive of, or in any way be associated in a management or ownership capacity with any corporation, company,
partnership or other enterprise or venture which conducts a business which is in direct competition with the business of the Company;
provided, however, that Executive may own not more than two percent (2%) of the outstanding securities, or equivalent equity
interests, of any class of any corporation, company, partnership, or either enterprise that is in direct competition with the business
of the Company, which securities are listed on a national securities exchange or traded in the over-the-counter market. For purposes
of this Agreement, a lump sum payment equivalent made to Executive shall be judged in relation to his most recent annual base salary
to determine whether Executive is continuing to receive a Severance Benefit or Severance Amount and shall be measured from the
date such payment is received. It is expressly agreed that the remedy at law for breach of this covenant is inadequate and that
injunctive relief shall be available to prevent the breach thereof.

 

6.3           Non-Solicitation.
Executive also agrees that he will not, directly or indirectly, during the term of his employment or within one (1) year after
termination of his employment for any reason, in any manner, encourage, persuade, or induce any other employee of the Company to
terminate his employment, or any person or entity engaged by the Company to represent it to terminate that relationship without
the express written approval of the Company; provided, however, that in the event an employee with whom the Executive had
a preexisting relationship prior to his employment with the Company individually elects to resign as a consequence of the Executive’s
having left the Company’s employ, this non-solicitation provision in this Section 6.3 shall not prohibit their subsequent
association. It is expressly agreed that the remedy at law for breach of this covenant is inadequate and that injunctive relief
shall be available to prevent the breach thereof.

 

ARTICLE
SEVEN 

 

MISCELLANEOUS

 

7.          Miscellaneous.

 

7.1           Benefit.
This Agreement shall inure to the benefit of and be binding upon each of the Parties, and their respective successors. This Agreement
shall not be assignable by any Party without the prior written consent of the other Party. The Company shall require any successor,
whether direct or indirect, to all or substantially all the business and/or assets of the Company expressly to assume and agree
to perform, by instrument in a form reasonably satisfactory to Executive, this Agreement and any other agreements between Executive
and the Company or any of its subsidiaries, in the same manner and to the same extent as the Company.

 

7.2           Covenants
of Article VI Are Essential Independent Covenants.
The covenants by Executive in Article VI are essential elements of this Agreement, and without Executive’s agreement to comply
with such covenants, the Company would not have entered into this Agreement or employed Executive. The Company and the Executive
have independently consulted with their respective counsel and have been advised in all respects concerning the reasonableness
and propriety of such covenants, with specific regard to the nature of the business conducted by the Company.

 

     

     

    

 

If
Executive’s employment hereunder expires or is terminated, this Agreement will continue in full force and effect as is necessary
or appropriate to enforce the covenants and agreements of Executive in Article VI.

 

7.3           Governing
Law. This Agreement shall be governed by,
and construed in accordance with the laws of the State of Delaware without resort to any principle of conflict of laws that would
require application of the laws of any other jurisdiction except as may apply to the Executive pursuant to applicable employment
or related laws of the United Kingdom; provided, however, that Delaware law shall govern with respect to the Executive’s
rights under a Change of Control.

 

7.4           Counterparts.
This Agreement may be executed in counterparts and via facsimile, each of which shall be deemed to constitute an original, but
all of which together shall constitute one and the same Agreement. Each such counterpart shall become effective when one counterpart
has been signed by each Party thereto.

 

7.5           Headings.
The headings of the various articles and sections of this Agreement are for convenience of reference only and shall not be deemed
a part of this Agreement or considered in construing the provisions thereof.

 

7.6           Severability.
Any term or provision of this Agreement that shall be prohibited or declared invalid or unenforceable in any jurisdiction shall,
as to such jurisdiction, be ineffective only to the extent of such prohibition or declaration, without invalidating the remaining
terms and provisions hereof or affecting the validity or enforceability of such provision in any other jurisdiction, and if any
term or provision of this Agreement is held by any court of competent jurisdiction to be void, voidable, invalid or unenforceable
in any given circumstance or situation, then all other terms and provisions hereof, being severable, shall remain in full force
and effect in such circumstance or situation, and such term or provision shall remain valid and in effect in any other circumstances
or situation.

 

7.7           Construction.
Use of the masculine pronoun herein shall be deemed to refer to the feminine and neuter genders and the use of singular references
shall be deemed to include the plural and vice versa, as appropriate. No inference in favor of or against any Party shall be drawn
from the fact that such Party or such Party’s counsel has drafted any portion of this Agreement.

 

7.8           Equitable
Remedies. The Parties hereto agree that,
in the event of a breach of this Agreement by either Party, the other Party, if not then in breach of this Agreement, may be without
an adequate remedy at law owing to the unique nature of the contemplated relationship. In recognition thereof, in addition to (and
not in lieu of) any remedies at law that may be available to the non-breaching Party, the non-breaching Party shall be entitled
to obtain equitable relief, including the remedies of specific performance and injunction, in the event of a breach of this Agreement,
by the Party in breach, and no attempt on the part of the non-breaching Party to obtain such equitable relief shall be deemed to
constitute an election of remedies by the non-breaching Party that would preclude the non-breaching Party from obtaining any remedies
at law to which it would otherwise be entitled.

 

     

     

    

 

7.9           No
Waiver. No failure, delay or omission of
or by any Party in exercising any right, power or remedy upon any breach or default of any other Party, or otherwise, shall impair
any such rights, powers or remedies of the Party not in breach or default, nor shall it be construed to be a waiver of any such
right, power or remedy, or an acquiescence in any similar breach or default; nor shall any waiver of any single breach or default
be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval
of any kind or character on the part of any Party of any provisions of this Agreement must be in writing and be executed by the
Parties and shall be effective only to the extent specifically set forth in such writing.

 

7.10         Remedies
Cumulative. All remedies provided in this
Agreement, by law or otherwise, shall be cumulative and not alternative.

 

7.11         Amendment.
This Agreement may be amended only by a writing signed by all of the Parties hereto.

 

7.12         Entire
Contract. This Agreement and the documents
and instruments referred to herein constitute the entire contract between the parties to this Agreement and supersede all other
understandings, written or oral, with respect to the subject matter of this Agreement.

 

7.13         Survival.
This Agreement shall constitute a binding obligation of the Company and any successor thereto. Notwithstanding any other provision
in this Agreement, the obligations under Articles 5 and 6 shall survive termination of this Agreement.

 

7.14         Savings
Clause. Notwithstanding any other provision
of this Agreement, if the indemnification provisions in Exhibit B
hereto or any portion thereof shall be invalidated on any ground by any court of competent jurisdiction, then the Company shall
nevertheless indemnify Executive as to Expenses, judgments, fines, penalties and amounts paid in settlement with respect to any
Proceeding to the full extent permitted by any applicable portion of this Agreement that shall not have been invalidated and to
the fullest extent permitted by applicable law.

 

7.15         Modifications
and Waivers. Notwithstanding any other provision
of this Agreement, the indemnification provisions in Exhibit B
hereto and the Change of Control provisions in Article Seven herein, may be amended from time to time to reflect changes in Delaware
law or for other reasons.

 

7.16         Notices.
All notices, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been given (i)
when delivered by hand or (ii) if mailed by certified or registered mail with postage prepaid, on the third day after the date
on which it is so mailed:

 

     

     

    

 

	(a)	if to Executive:
	 	 
	 	Lee Broad 

Units 5, 6, & 7,
	 	Maple Park, Maple Court,
	 	Tankersley,
	 	Barnsley, S75 3DP, UK
	 	 
	(b)	if to the Company:
	 	 
	 	MAM Software Group, Inc.
	 	c/o Robinson Brog
	 	875 3rd Avenue – 9th Floor
	 	New York, NY 10022
	 	Attn: Chairman, Compensation Committee

 

or
to such other address as may have been furnished to Executive by the Company or to the Company by Executive, as the case may be.

 

7.17         No
Limitation. Notwithstanding any other provision
of this Agreement, for avoidance of doubt, the parties confirm that the foregoing does not apply to or limit Executive’s
rights under Delaware law or the Company’s Corporate Documents.

 

[Signatures
Follow On Next Page]

 

     

     

    

 

IN
WITNESS WHEREOF, the parties have set their hands and seals hereunto on the date first above written.

 

	MAM SOFTWARE GROUP, INC.	 	EXECUTIVE
	 	 	 	 	 
	By:	 	 	By:	 
	Name:	Dwight Mamanteo	 	Name: 	Lee Broad
	Title:	Chairman, Compensation Committee	 	 	 

 

     

     

    

 

Schedule
A

 

Outside
Activities/Investments 

Lee
Broad

 

	Company or

Project Name	Nature of

Business	Date Hired or

Commenced

Involvement	Position	Compensation	Annual Time

Commitment, (time away

from office)
	 	 	 	 	 	 
	 	 	 	 	 	 
	 	 	 	 	 	 
	 	 	 	 	 	 

 

Dated:
July 1, 2013

 

Initials:              Executive:
______      Company: _______

 

     

     

    

 

Exhibit
A

 

SEVERANCE
AGREEMENT AND GENERAL RELEASE

 

This
Severance Agreement and General Release (“Agreement”) is entered into by and between Lee Broad (“Executive”)
and MAM Software Group, Inc. (hereinafter the “Company”) (Executive and the Company are each a “party”
to this Agreement and, when collectively referenced herein, Executive and the Company shall be referred to as the “Parties”),
and is made and entered into with reference to the following facts:

 

RECITALS

 

WHEREAS,
Executive was hired by the Company in 200_ and has held the position of the Company’s Chief Technology Officer since July
1, 2013, and

 

WHEREAS,
Executive’s employment with the Company has been terminated effective __ (the “Termination Date”);
and

 

WHEREAS,
the Company and Executive desire to resolve, fully and finally, any and all claims or disputes that exist or may exist between
them through the date of this Agreement.

 

AGREEMENT

 

NOW
THEREFORE, in consideration of the covenants and premises contained herein, the Parties hereto agree as follows:

 

1.          Agreement
by the Company. Prior to the execution of this
Agreement, Company will pay Executive all Base Salary and for the value of all unused vacation earned through the date of
termination. Company will also pay Executive for any Target Bonus awarded by the Board of Directors but not yet paid. In
exchange for Executive’s agreement to the releases and other terms and conditions of this Agreement, the Company agrees
to provide Executive, after the Effective Date (as defined below) of this Agreement, a total gross lump sum payment of $___,
which is equal to (a) 1 year of his Base Salary based upon his current Base Salary of $___; (b) plus $___, which is equal [_________].
[Insert other benefits if applicable.]

 

2.          Agreement
by the Executive. By signing this Agreement and accepting
the payment set forth in Section 1 above, Executive agrees to be bound by the terms of this entire Agreement. Executive further
agrees to be bound by the surviving terms of the agreements he entered into as an employee of the Company.

 

     

     

    

 

3.          Release
of Claims. In exchange for the consideration provided in
Section 1 above, Executive hereby expressly waives, releases, acquits and forever discharges the Company and its parents, successors,
assigns, divisions, subsidiaries, affiliates, partners, officers, directors, executives, investors, shareholders, managers, supervisors,
employees, agents, attorneys and representatives (hereinafter the “Released Parties” or “Releasees”), from
any and all claims, demands, and causes of action which Executive has or claims to have, whether known or unknown, of whatever
nature, which exist or may exist as of the date of Executive’s execution of this Agreement. As used in this paragraph, “claims,”
“demands,” and “causes of action” include, but are not limited to, contract claims, equitable claims, fraud
claims, tort claims, discrimination claims, harassment claims, retaliation claims, personal injury claims, constructive discharge
claims, emotional distress claims, public policy claims, wage claims, claims for debts, accounts, attorneys’ fees, compensatory
damages, punitive damages, and/or liquidated damages, claims for the Company’s stock or options to purchase the Company’s
stock, claims for vesting or accelerated vesting of options to purchase the Company’s Common Stock, claims for defamation,
and any and all claims arising under the Americans with Disabilities Act, the Family and Medical Leave Act, or any other federal
or state statute governing employment, including but not limited to Title VII of the Civil Rights Act of 1964, the Age Discrimination
in Employment Act, 29 U.S.C. § 621 et seq., or their equivalent in the United Kingdom and any other federal, state or local
statute governing any aspect of the employer/employee relationship.

 

4.          Release
of Claims for Age Discrimination. Without in any way limiting
the generality or scope of Section 3 of this Agreement, Executive hereby understands and agrees to release any and all claims,
rights or benefits Executive has or may have for age discrimination arising out of or under the Age Discrimination in Employment
Act of 1967 (“ADEA”), 29 U.S.C. § 621, et seq., (or its equivalent in the United Kingdom) as the ADEA may have
been or may be amended, or any equivalent or comparable provision of state or local law, without limitation.

 

5.          Release
of Unknown Claims. Executive understands and agrees, in
compliance with any statute or ordinance which requires a specific release of unknown claims or benefits, that this Agreement includes
a release of unknown claims, and Executive hereby expressly waives and relinquishes any and all claims, rights or benefits that
Executive may have which are unknown to Executive at the time of the execution of this Agreement.

 

6.          Indemnification
Agreement. Executive’s and Company’s
rights and responsibilities under the Indemnification Agreement dated [______] between Executive and
Company will continue in effect and will not be affected by this Agreement.

 

7.          Sufficiency
of Consideration. Executive acknowledges and agrees that
absent this Agreement, Executive has no legal entitlement to the consideration provided in this Agreement and that the consideration
represents good and sufficient value for the releases and other agreements of Executive set forth in this Agreement.

 

8.          Non-Admission
of Liability. Executive understands that the Company denies
that it has engaged in any wrongdoing whatsoever in connection with its dealings with Executive and that nothing in this Agreement
shall constitute or be treated as an admission of any wrongdoing or liability on the part of the Company and/or the Released Parties.

 

     

     

    

 

9.          Consultation
with an Attorney. Executive is advised to consult with
an attorney of his choosing prior to entering into this Agreement.

 

10.         Acceptance
of Agreement. Executive has up to twenty-one (21) days
after the Termination Date to consider this Agreement and Executive may revoke this Agreement at any time during the first seven
(7) days following Executive’s execution of this Agreement by delivering written notice of revocation to the Secretary of
the Company’s Board of Directors, no later than five (5:00) p.m. on the seventh (7th) day after execution. Executive received
this Agreement on ___, 2013. The settlement offer contained in this Agreement will automatically expire if this Agreement, fully
executed by Executive, is not received by the Secretary of the Company’s Board of Directors, on or before ___, 201___.

 

11.         Effective
Date of Agreement. This Agreement will become effective,
irrevocable and fully enforceable upon the expiration of seven (7) days following the date of Executive’s execution of this
Agreement (the “Effective Date”), provided that Executive has executed and submitted to the Company the executed original
of this Agreement in a timely manner as set forth in Section 10 and Executive has not exercised Executive’s right to revoke
this Agreement as set forth in Section 10.

 

12.         No
Filing of Claims. Executive represents and warrants that
Executive does not presently have on file, and further represents and warrants that Executive will not hereafter file, any claims,
charges, grievances or complaints against the Company and/or the Released Parties in or with any administrative, state, federal
or governmental entity, agency, board or court, or before any other tribunal or panel or arbitrators, public or private, based
upon any actions or omissions by the Company and/or the Released Parties occurring prior to the date of Executive’s execution
of this Agreement.

 

13.         Ownership
of Claims. Executive represents and warrants that Executive
is the sole and lawful owner of all rights, title and interest in and to all released matters, claims and demands arising out of
or in any way related to Executive’s employment with the Company and/or the resignation thereof.

 

14.         Successors
and Assigns. Executive understands and agrees that this
Agreement and all of its terms shall be binding upon Executive’s representatives, heirs, executors, administrators, successors,
and assigns.

 

15.         Tax
Liability.
Executive acknowledges and agrees that he has obtained no
advice from Releasees (defined above) and that neither Releasees, nor their attorneys, have made any representation regarding
the tax consequences, if any, of Executive’s receipt of the settlement amounts and other consideration provided for in this
Agreement. Executive further acknowledges and agrees that he is personally responsible for the payment of all federal, state and
local taxes that are due, or may be due, for any payments and other consideration received by Executive under this Agreement.
Executive agrees to indemnify the Company and hold the Company harmless for any and all taxes, penalties and/or other assessments
that the Company is, or may become, obligated to pay on account of any payments and other consideration made to Executive under
this Agreement.

 

     

     

    

 

16.         Attorneys’
Fees. Executive understands and agrees that in any dispute
between Executive and the Company regarding the terms of this Agreement and/or any alleged breach thereof, that the prevailing
party will be entitled to recover its costs and reasonable attorneys’ fees arising out of such dispute.

 

17.         Confidentiality.
Executive understands and agrees that the terms and existence
of this Agreement and any other terms or information relating to the resignation of Executive’s employment with the Company
are strictly confidential and may not be disclosed to any other person or entity, with the exception of Executive’s immediate
family members and legal and financial advisors.

 

18.         Continuing
Obligations. Executive and Company understand and agree
that certain obligations set forth in the Executive Employment Agreement between the Parties of July 1, 2013, as it may have been
amended from time to time, a copy of which is attached hereto (at the time of execution) as Exhibit A and incorporated herein by
this reference, continue beyond termination of his employment with the Company. Those obligations include those set forth in Sections
[______] of that Agreement. Executive further understands and agrees that a breach of any continuing obligation contained in the
Company’s Executive Employment Agreement shall also constitute a breach of this Agreement.

 

19.         Non-Disparagement.
Executive agrees that he will not disparage or in any way criticize the Company and/or its officers, managers, supervisors,
employees, investors, products, services, or technology at any time in the future. Nothing contained in this Section is intended
to prevent Executive from testifying truthfully in any legal proceeding.

 

20.         Headings.
The headings in each section herein are for convenience of
reference only and shall be of no legal effect in the interpretation of the terms hereof.

 

21.         Integration.
This Agreement, and the surviving provisions of the accompanying
Exhibit A, constitute an integrated; written contract, expressing the entire agreement between the Parties with respect to the
subject matter hereof. In this regard, Executive represents and warrants that he is not relying on any promises or representations
which do not appear written herein. Executive further understands and agrees that this Agreement can be amended or modified only
by a written agreement, signed by all of the Parties hereto.

 

22.         Delaware
Law Applies. This Agreement shall, in all respects, be
interpreted, enforced and governed under the laws of the State of Delaware applicable to contracts executed and performed in Delaware
without giving effect to conflicts of law principles, except where the Executive has rights under the laws of the United Kingdom.

 

     

     

    

 

23.         Severability.
Executive agrees that if any provision, or portion thereof,
of this Agreement is held to be invalid or unenforceable or to be contrary to public policy or any law, for any reason, the remainder
of the Agreement shall not be affected thereby.

 

24.         Execution
by Counterparts/Facsimile. This Agreement may be executed
in separate counterparts and by facsimile, and each such counterpart shall be deemed an original with the same effect as if all
parties signed the same document.

 

EXECUTIVE
UNDERSTANDS AND AGREES THAT EXECUTIVE MAY BE WAIVING SIGNIFICANT LEGAL RIGHTS BY SIGNING THIS AGREEMENT, AND REPRESENTS THAT EXECUTIVE
HAS ENTERED INTO THIS AGREEMENT VOLUNTARILY, AFTER HAVING THE OPPORTUNITY TO CONSULT WITH AN ATTORNEY OF EXECUTIVE’S OWN
CHOOSING, WITH A FULL UNDERSTANDING OF AND IN AGREEMENT WITH ALL OF ITS TERMS.

 

IN
WITNESS WHEREOF, the Parties have executed this Agreement on the date provided below.

 

     

     

    

 

Exhibit
B 

 

Indemnification
AgreementExhibit 10.1

 

CERTAIN CONFIDENTIAL INFORMATION CONTAINED
IN THIS AGREEMENT AND THE SCHEDULES HERETO MARKED BY *** HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

 

THIS SPECIFIC AGREEMENT is entered into
by the Commission of the National Council for Scientific and Technological Research (Consejo Nacional de Investigaciones
Cientificas y Técnicas, CONICET), hereupon represented by its President, Eduardo Charreau, domiciled at Rivadavia 1917,
Capital Federal, hereinafter referred to as “CONICET”; Universidad Nacional del Litoral, hereupon represented
by its Rector, Engineer Mario Domingo Barletta, domiciled at Bv. Pellegrini 2750, Santa Fe, hereinafter referred to as “THE
UNL;” on the one hand, and on the other Bioceres Sociedad Anónima, hereupon represented by Engineer Gustavo Grobocopatel
in his capacity of President, being its legal address Paraguay 777, 8th floor, office 4, Rosario, province of Santa
Fe, hereinafter referred to as “THE COMPANY.”

 

BACKGROUND

 

FIRST:

 

The team jointly directed by PhD Raquel
Chan and PhD Daniel H. González has developed certain findings which are useful for the future development of genetically modified
drought-resistant plants.

 

SECOND:

 

The Parties desire to set forth the terms
and conditions under which CONICET and THE UNL shall perform research work aimed at consolidating and contributing to the improvement
of the findings made by PhD Chan and PhD González’s team, in order to develop genetically modified drought-resistant plants
for commercial use.

 

    	 

    	 

    

  

THIRD:

 

The Company is interested in this development
and desires to obtain an exclusive license to use the results of the development or exploit them commercially, whether the results
turn out to be patentable or not.

 

FOURTH:

 

THE COMPANY has so far provided the funds,
up to the amount of *** Argentine pesos (*** AR$), necessary to draft and file:

 

a) A patent application in Argentina, over
the findings of the team jointly directed by PhD Raquel Chan and PhD Daniel H. González, File No. P030101532: “Gen de
un factor de transcripción inducible por condiciones de estrés hίdrico y ácido abscίsico de Helianthus annuus, promoter y plantas
transgénicas (Transcription factor gene induced by water deficit conditions and abscisic from Helianthus annuus, promoter and
transgenic plants),” and

 

b) A patent application under the provisions
of the Patent Cooperation Treaty (PCT), File No. 1422P-PCT: “Transcription factor gene induced by water deficit conditions
and abscisic from Helianthus annuus, promoter and transgenic plants”, hereinafter referred to as “the PATENTS.”

 

NOW, THEREFORE, the Parties agree as follows:

 

PROVISIONS:

 

FIRST: PURPOSE

 

By virtue of this Agreement the COMPANY
commissions CONICET and THE UNL the conduction of research related to the optimization of a system to obtain drought-resistant
Arabidopsis thaliana plants using Genetic Engineering techniques that allow to properly express the sunflower hahb-4
gene, which is the subject of the PATENTS, hereinafter referred to as “THE PROJECT”.

 

 

	*** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

 

    	 

    	 

    

 

THE PROJECT shall be carried out in accordance
with the specifications set forth in the work plan as described in Exhibit I herein.

 

SECOND: PROJECT EXECUTING UNIT

 

The performance of the work undertaken
by CONICET and THE UNIVERSITY shall be executed by a team of researchers, teachers, and interns of the Chair of Cellular and Molecular
Biology (Cátedra de Biologίa Celular y Molecular) of the School of Biochemistry and Biological Sciences (Facultad de Bioquίmica
y Ciencias Biológicas) of Universidad Nacional del Litoral.

 

THIRD: TECHNICAL DIRECTION

 

For the purpose of this Agreement, the
Parties shall appoint technical directors to create permanent and effective channels of communications. CONICET and THE UNL appoint
PhD Raquel Chan technical director. For its part, THE COMPANY appoints PhD Miguel Lucero.

 

FOURTH: OBLIGATIONS OF CONICET AND THE
UNL 

 

The obligations of CONICET and THE UNL are as follows:

 

a) To perform the activities set forth
in the work plan as described in Exhibit I herein.

 

b) To submit three (3) quarterly reports,
which shall account for the advances achieved regarding the results, and a comprehensive final report indicating the results obtained.
The report submission terms shall be calculated as of the date of execution of this Agreement.

 

    	 

    	 

    

 

c) To record research-related progress
on signed and sealed books on a biweekly basis, according to what Parties agree.

 

FIFHT: OBLIGATIONS OF THE COMPANY

 

The obligations of THE COMPANY shall be
as follows:

 

a) To monitor and follow up the performance
of the activities specified in the first provision and in Exhibit I herein.

 

b) To provide the agreed upon funds according
to the estimate specified in Exhibit II herein.

 

c) To pay “CONICET” and “THE
UNIVERSITY” a percentage of the profits which may arise from trading technological development of plants with commercial
interest, or from sublicensing and/or trading the results before obtaining drought-tolerant plants species of commercial interest.

 

d) To afford at its own cost all expenses
related to patent application, prosecution and maintenance, including the assignment of rights and other expenditures incurred
because of the PATENTS application, follow-up and advocacy on behalf of CONICET and THE UNL. It is up to THE COMPANY to decide
in which countries the patent National stage under the terms of PCT shall be entered into, according to the potential market of
each country.

 

SIXTH: DURATION AND TERMINATION.

 

This agreement shall be binding upon the
Parties from the execution thereof; its validity term shall be twelve (12) months from the start-up date of the activities, except
for the ninth to eleventh provisions, and the twentieth provision, which shall remain in full effect thereon.

 

Failure to comply
with any of the obligations established herein by either of the parties shall entitle the non-defaulting party to terminate this
agreement. To that end, the non-defaulting party shall demand the defaulting party by sufficient means to observe and perform any
unfulfilled obligation arising from this agreement on its part to be observed or performed hereunder, under penalty of termination.
Should the defaulting party fail to observe and perform such unfulfilled obligation within thirty (30) days after the receipt of
written notice thereof from the non-defaulting party, the latter may terminate this agreement. In such case, the parties shall
mutually decide the manner in which the work in progress is to be concluded. That being the case, CONICET and THE UNL shall provide
THE COMPANY a report of the results obtained so far and the provisions hereto about the rights of invention, ownership and commercial
exploitation shall remain in force.

 

    	 

    	 

    

 

Should the agreement be terminated due
to default by CONICET, all the information, protocols, results, and procedures related to and obtained by virtue of the project
shall be and remain the sole propriety of THE COMPANY. Should the agreement be terminated due to default by THE COMPANY, all the
information, protocols, results, and procedures related to and obtained by virtue of the project shall be and remain the propriety
of CONICET and/or THE UNL in equal parts.

 

SEVENTH: PRICE:

 

THE COMPANY shall pay for the project as
described in Exhibit I herein the total sum of *** Argentine pesos (*** AR$.) Such payment shall be made as follows: Eleven consecutive
installments of *** Argentine pesos (*** AR$.) on a monthly basis, after the execution thereof; and a final payment of *** Argentine
pesos (*** AR$) for the twelfth month. All payments due under the terms of this agreement shall be made by deposit of immediately
available funds to the bank designated by CONICET and THE UNL, as per agreed in the estimate attached hereto as Exhibit II.

 

 

	*** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

 

    	 

    	 

    

 

EIGHT: FUND ADMINISTRATION

 

The Parties agree to commission the administration
of the funds which constitute the price paid by THE COMPANY to THE UNL, as per the previous provision, which shall act as Unit
of Technological Cooperation (Unidad de Vinculación Tecnológica.) Of such amount, THE UNL shall retain ***% as administration expenses,
and shall transfer to CONICET, to a bank specific account, another ***% of such amount as an institutional contribution. THE UNL
shall administer the remaining ***% of the funds provided by THE COMPANY according to the instructions of the project’s technical
direction, which shall be in compliance with the terms and conditions herein. THE UNL shall provide notice to CONICET of such administration
acts.

 

NINTH: INTELLECTUAL PROPERTY RIGHTS

 

All intellectual property rights related
to the results obtained under this agreement, whether partial or final, shall be and remain the propriety of CONICET and THE UNIVERSITY,
in equal shares. Patents already applied for and those to be applied for in the future, and any other kind of legal registration
concerning the results obtained under this agreement, whether in Argentina or in any country, shall be and remain the propriety
of CONICET and THE UNL. Neither CONICET, nor THE UNL, nor THE COMPANY, shall file or prosecute patent applications or any other
intellectual or industrial property rights over the results obtained under this agreement, whether before Argentine or foreign
authorities or entities. Notwithstanding the provisions above, both CONICET and THE UNIVERSITY shall acknowledge the right of the
intervening teachers and researchers to be identified as inventors in the patents to be applied for.

 

 

	*** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

 

    	 

    	 

    

 

TENTH: PATENT APPLICATION EXPENSES

 

All expenses related to the process of application, follow-up, procurement or maintenance of intellectual
property rights related to pending patents, and all expenses related to any other patent applied for at the national stage of the
Patent Cooperation Treaty (PCT), or any patents applied for over the results obtained from the project to be carried out under
this agreement, shall be afforded by THE COMPANY at its own cost.

 

ELEVENTH: LICENSE - SHARE OF THE PROFITS

 

CONICET and THE UNL grant THE COMPANY an
exclusive license over the use or commercial exploitation of the PATENTS, as well as over the results obtained as per this agreement,
whether patented or not, hereinafter referred to as THE RESULTS.

 

As a retribution for this license, THE COMPANY agrees to pay CONICET
and THE UNL a percentage of the Net Profits earned from the trading of any product that contains or is manufactured as per the
RESULTS and/or the PATENTS; or the Gross Profits earned from granting sublicenses to third parties. To that end, Net Profits shall
mean and refer to Profits minus investment minus the expenses incurred.

 

TWELFTH: SHARE OF PROFITS ACCORDING
TO TECHNOLOGICAL MILESTONES:

 

In order to reach an equitable share of
the profits referred to in the provision above, the Parties agree that the project purpose of this Agreement represents one stage
in the technological development of the plants of commercial interest, and that the share of the profits may vary as follows as
technological milestones are achieved:

 

a) As regards profits arising from the trading of the technological development occurred
before the end of stage 1 of the research project directed by PhD Raquel Chan under this agreement, *** percent (***%)
 of THE COMPANY’s profits correspond to CONICET and THE UNL in equal shares, and *** percent (***%) to THE COMPANY.

 

 

	*** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

 

    	 

    	 

    

 

b) As regards profits arising from the trading of the technological development occurred
after the end of stage 2, that is, after the fulfillment of stage 1 and the transformation of crops of commercial interest, ***
percent (***%) of THE COMPANY’s profits correspond to THE COMPANY and *** percent (***%) shall be distributed as follows:
*** percent (***%) corresponds to CONICET and THE UNL in equal shares, and *** percent (***%) corresponds to the Institution that
carries out the transformation of the crop of commercial interest.

 

c) As regards profits arising from the
trading of the technological development occurred after the end of stage 3, that is, after the fulfillment of stages 1 and 2 and
of the field trials, *** percent (***%) of THE COMPANY’s profits correspond to THE COMPANY and *** percent (***%) snail be
distributed as follows: *** percent (***%) corresponds to CONICET and THE UNL in equal shares, *** percent (***%) corresponds to
the institution that carries out the transformation of crop of commercial interest, and *** percent (***%) corresponds to the institution
that practices the field trials.

 

Notwithstanding the provisions of this article, both CONICET and THE UNL acknowledge, according
to their internal regulations, the right of the intervening teachers and researchers to have a share of profits.

 

THE COMPANY shall not be held liable for
the payment of royalties or any other kind of compensation to the intervening teachers or researchers with regard to the profits
earned from the commercialization or exploitation of the PATENTS.

 

 

	*** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

 

    	 

    	 

    

 

The Institutions that may participate in
the performance of stages 2 and 3 shall represent their knowledge and acceptance of the terms and conditions herein, especially
as regards the percentages set forth in this provision.

 

THIRTEENTH: COMMERCIALIZATION – SALE
OF PRODUCTS BY THIRD PARTIES - SUBLICENSES

 

THE COMPANY may grant sublicenses to third
parties over the PATENTS and/or RESULTS obtained under this agreement, at any stage or technological milestone described before,
and shall pay CONICET and THE UNL the share of the profits specified in the TWELFTH provision.

 

If a third party sells a product
acting as a sales agent of THE COMPANY, THE COMPANY shall notice CONICET and UNL and liquidate the profits as if the products that
contain or are manufactured as per the PATENTS and/or the RESULTS were sold directly by THE COMPANY.

 

FORTEENTH: REPORTS - TERMS - AUDITS

 

Whether THE COMPANY decides to grant sublicenses
or to exploit the PATENTS and/or the RESULTS commercially, directly or through third parties, pursuant to the TWELFHT provision,
CONICET and THE UNL shall be entitled to a share in the profits over the fixed sums collected, or over the sales volume in case
of commercial exploitation, direct or through third parties, that shall be made effective within sixty (60) consecutive days after
the expiration of each royalty period. Liquidations for CONICET and THE UNL shall be accompanied by a report of THE COMPANY indicating
the way in which such payment was calculated. THE COMPANY agrees to keep updated and complete records of the sales of products
that contain or are manufactured as per the PATENTS and/or RESULTS, whether such sales take place through third parties on behalf
of THE COMPANY or by THE COMPANY itself. THE COMPANY shall allow CONICET, THE UNL, or a designated person, to audit its accounting
records and to inspect the industrial plant and/or production sites of the products containing or manufactured as per the PATENTS
and/or the RESULTS. The expenses arising from such audits shall be afforded solely by whoever performs them.

 

    	 

    	 

    

 

FIFTEENTH: FAILURE TO EXPLOIT THE RESULTS
COMMERCIALLY

 

If THE COMPANY fails to commercially exploit
or to sufficiently exploit the patents and/or the research results obtained under this agreement, at CONICET and THE UNL’s
request, both Institutions may agree either to revoke the license, in which case THE COMPANY shall be entitled to recover the expenses
incurred because of the RESULTS development, or to continue the joint ownership granting exploitation licenses over the PATENTS
and/or RESULTS to other Companies. To that extent, insufficient exploitation shall be deemed to have occurred if the industrial
and commercial implementation of a final product does not take place within twenty-four (24) months of the date in which such implementation
could have begun. This term may be extended due to technical difficulties considered reasonable by CONICET, THE UNL and THE COMPANY’S
technical directors, as well as due to delays beyond THE COMPANY and/or its sublicensees’ control related to the process
of industrial plant and product approval by applicable authorities.

 

SIXTEENTH: CONFIDENTIALITY

 

The Parties hereto agree to preserve the
confidentiality of the information which comes to their knowledge because of the PROJECT under this agreement, which shall not
be disclosed to, used or acquired by third parties without the proprietary party’s consent. This obligation of confidence
shall remain in full force even in the event of termination of this agreement.

 

    	 

    	 

    

 

Additionally, CONICET, THE UNL and THE
COMPANY agree to preserve the confidentiality of the research performed under this Agreement. To that end, each Party shall take
the necessary measures to ensure the confidential treatment of the information by its employees, and shall be liable for any infringement
by its employees to the provisions hereof.

 

Confidential information refers to all
the information that is so labeled by the disclosing party. The information complying with the terms specified under Argentine
Law No. 24.766 shall be regarded as confidential, namely:

 

“Information which is secret, in
that it is not publicly known or easily accessible, as a whole or in the exact configuration of its components, by those involved
in the fields in which such information is normally used; b) Information with trade value due to its confidentiality; c) Information
which has been subject to reasonable measures taken by those who have legitimate control over it to maintain its confidentiality.”

 

The non-disclosure obligation involves all information, whether it may be provided orally, in writing, or via electronic or magnetic
means, optical disk, microfilm, film or by any other means.

 

SEVENTEENTH: PUBLICATION

 

None of the Parties shall make the results
obtained under this agreement public without the other Parties’ written consent. Any publication made shall refer to the
parties hereinto and mention that the publication is the result of research conducted as per this agreement, as well as its authors
and the extent of their participation.

 

    	 

    	 

    

 

THE COMPANY shall make reference to the
participation of CONICET, THE UNL and the intervening researchers when disclosing any information related to the products containing
the PATENTS and/or the RESULTS.

 

EIGHTEENTH: NO EXPENDITURES IN CHARGE
OF CONICET AND THE UNL

 

No expenditures of any kind whatsoever
shall be due by CONICET or THE UNL by virtue of the execution of this agreement.

 

NINETEENTH: CONTRACTUAL NATURE OF THE
RELATIONSHIP

 

This Agreement shall not be deemed as a
partnership among the Parties. Therefore, as regards the obligations undertaken by each party that have not been specified in this
agreement, the parties are not to be held jointly and severally liable. CONICET and THE UNL accept exclusive liability for payment
of payroll taxes for its employees who are to participate in the research object of this agreement.

 

TWENTIETH: CONFLICT RESOLUTION

 

All claims, disputes and controversies
arising out of, or relating to this agreement shall be resolved by mutual agreement. The Parties hereto shall endeavor to bring
the dispute to an end by arriving at a mutual decision. Should the Parties fail to arrive at a mutual decision, they shall submit
the dispute to the jurisdiction of the Federal Courts of Capital Federal.

 

TWENTY FIRST: DOMICILES - NOTICES

 

For all purposes of this agreement, the
Parties hereto establish their elected domiciles at the addresses first mentioned, or at the ones to be sufficiently informed in
the future, where all notices and communications hereunder shall be validly served.

 

    	 

    	 

    

 

IN WITNESS WHEREOF, both Parties have caused
this Agreement to be duly executed in three counterparts of the same tenor and to a sole effect, which are signed in the city of
Buenos Aires on the ___ day of ___ 2003.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00249-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00249-of-00352.parquet"}]]